El-Chemaly S - Search Results

1

Towards personalised therapy for lymphangioleiomyomatosis: lessons from cancer.

El-Chemaly S, Henske EP. El-Chemaly S, et al. Eur Respir Rev. 2014 Mar 1;23(131):30-5. doi: 10.1183/09059180.00008813. Eur Respir Rev. 2014. PMID: 24591659 Free PMC article. Review.

2

Lymphatics in lymphangioleiomyomatosis and idiopathic pulmonary fibrosis.

Glasgow CG, El-Chemaly S, Moss J. Glasgow CG, et al. Eur Respir Rev. 2012 Sep 1;21(125):196-206. doi: 10.1183/09059180.00009311. Eur Respir Rev. 2012. PMID: 22941884 Free PMC article. Review.

3

Should mammalian target of rapamycin inhibitors be stopped in women with lymphangioleiomyomatosis awaiting lung transplantation?

El-Chemaly S, Goldberg HJ, Glanville AR. El-Chemaly S, et al. Expert Rev Respir Med. 2014 Dec;8(6):657-60. doi: 10.1586/17476348.2014.956728. Epub 2014 Sep 9. Expert Rev Respir Med. 2014. PMID: 25199529

4

Prevalence and outcome of lung cancer in lung transplant recipients.

Grewal AS, Padera RF, Boukedes S, Divo M, Rosas IO, Camp PC, Fuhlbrigge A, Goldberg H, El-Chemaly S. Grewal AS, et al. Respir Med. 2015 Mar;109(3):427-33. doi: 10.1016/j.rmed.2014.12.013. Epub 2015 Jan 7. Respir Med. 2015. PMID: 25616348 Free article.

5

The next breakthrough in LAM clinical trials may be their design: challenges in design and execution of future LAM clinical trials.

El-Chemaly S, Henske EP. El-Chemaly S, et al. Expert Rev Respir Med. 2015 Apr;9(2):195-204. doi: 10.1586/17476348.2015.1024663. Epub 2015 Mar 10. Expert Rev Respir Med. 2015. PMID: 25757365 Review.

6

The effect of mTOR inhibitors on respiratory infections in lymphangioleiomyomatosis.

Courtwright AM, Goldberg HJ, Henske EP, El-Chemaly S. Courtwright AM, et al. Eur Respir Rev. 2017 Jan 17;26(143):160004. doi: 10.1183/16000617.0004-2016. Print 2017 Jan. Eur Respir Rev. 2017. PMID: 28096282 Free PMC article. Review.

7

Sirolimus and Autophagy Inhibition in Lymphangioleiomyomatosis: Results of a Phase I Clinical Trial.

El-Chemaly S, Taveira-Dasilva A, Goldberg HJ, Peters E, Haughey M, Bienfang D, Jones AM, Julien-Williams P, Cui Y, Villalba JA, Bagwe S, Maurer R, Rosas IO, Moss J, Henske EP. El-Chemaly S, et al. Chest. 2017 Jun;151(6):1302-1310. doi: 10.1016/j.chest.2017.01.033. Epub 2017 Feb 10. Chest. 2017. PMID: 28192114 Free PMC article. Clinical Trial.

8

Aberrant SYK Kinase Signaling Is Essential for Tumorigenesis Induced by TSC2 Inactivation.

Cui Y, Steagall WK, Lamattina AM, Pacheco-Rodriguez G, Stylianou M, Kidambi P, Stump B, Golzarri F, Rosas IO, Priolo C, Henske EP, Moss J, El-Chemaly S. Cui Y, et al. Cancer Res. 2017 Mar 15;77(6):1492-1502. doi: 10.1158/0008-5472.CAN-16-2755. Epub 2017 Feb 15. Cancer Res. 2017. PMID: 28202529 Free PMC article.

9

Spontaneous Pneumothoraces in Patients with Birt-Hogg-Dubé Syndrome.

Gupta N, Kopras EJ, Henske EP, James LE, El-Chemaly S, Veeraraghavan S, Drake MG, McCormack FX. Gupta N, et al. Ann Am Thorac Soc. 2017 May;14(5):706-713. doi: 10.1513/AnnalsATS.201611-886OC. Ann Am Thorac Soc. 2017. PMID: 28248571 Free PMC article.

10

Emerging biomarkers of lymphangioleiomyomatosis.

Nijmeh J, El-Chemaly S, Henske EP. Nijmeh J, et al. Expert Rev Respir Med. 2018 Feb;12(2):95-102. doi: 10.1080/17476348.2018.1409622. Epub 2017 Dec 1. Expert Rev Respir Med. 2018. PMID: 29171770 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page